Vancomycin-intermediate Staphylococcus aureus in a home health-care patient.
In June 2000, vancomycin-intermediate Staphylococcus aureus (VISA) was isolated from a 27-year-old home health-care patient following a complicated cholecystectomy. Two VISA strains were identified with identical MICs to all antimicrobials tested except oxacillin and with closely related pulsed-field gel electrophoresis types. The patient was treated successfully with antimicrobial therapy, biliary drainage, and reconstruction. Standard precautions in the home health setting appear successful in preventing transmission.
Hageman
J C
JC
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. jhageman@cdc.gov
Pegues
D A
DA
Jepson
C
C
Bell
R L
RL
Guinan
M
M
Ward
K W
KW
Cohen
M D
MD
Hindler
J A
JA
Tenover
F C
FC
McAllister
S K
SK
Kellum
M E
ME
Fridkin
S K
SK
D000328:Adult; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D004269:DNA, Bacterial / Q000032:analysis; D005260:Female; D006699:Home Care Services; D006801:Humans; D017758:Infectious Disease Transmission, Patient-to-Professional; D008826:Microbial Sensitivity Tests; D009726:Nurses; D012307:Risk Factors; D013203:Staphylococcal Infections / Q000382:microbiology* / Q000635:transmission; D013211:Staphylococcus aureus / Q000187:drug effects / Q000235:genetics / Q000254:growth & development; D014640:Vancomycin / Q000494:pharmacology*; D020713:Vancomycin Resistance / Q000235:genetics
D000900:Anti-Bacterial Agents; D004269:DNA, Bacterial; D014640:Vancomycin